Development and Validation of a Fluorescence in-situ Hybridization (FISH) Based Assay as an Adjunct to Histopathology in the Diagnosis of Melanoma Read more about Development and Validation of a Fluorescence in-situ Hybridization (FISH) Based Assay as an Adjunct to Histopathology in the Diagnosis of Melanoma
FISH as an effective diagnostic tool for the management of challenging melanocytic lesions Read more about FISH as an effective diagnostic tool for the management of challenging melanocytic lesions
Fluorescence in-situ Hybridization (FISH) in Atypical Melanocytic Proliferations and Melanoma of Young Patients Read more about Fluorescence in-situ Hybridization (FISH) in Atypical Melanocytic Proliferations and Melanoma of Young Patients
DNA Abnormalities in Benign Barrett’s Esophagus (BE) are associated with Subsequent Progression to Esophageal Adenocarcinoma (EAC) Read more about DNA Abnormalities in Benign Barrett’s Esophagus (BE) are associated with Subsequent Progression to Esophageal Adenocarcinoma (EAC)
Detection of Esophageal Adenocarcinoma (EAC) by a Four-Probe Fluorescence in situ Hybridization (FISH) Assay Read more about Detection of Esophageal Adenocarcinoma (EAC) by a Four-Probe Fluorescence in situ Hybridization (FISH) Assay
Fluorescent In Situ Hybridization: Utility and Limitations for the Analysis of Melanocytic Lesions Read more about Fluorescent In Situ Hybridization: Utility and Limitations for the Analysis of Melanocytic Lesions
A Case for Performing Molecular Analysis on Challenging Melanocytic Lesions Read more about A Case for Performing Molecular Analysis on Challenging Melanocytic Lesions
A rare case of a complex variant Philadelphia chromosome translocation in CML Read more about A rare case of a complex variant Philadelphia chromosome translocation in CML
Feasibility of Peripheral Blood Sampling and Correlation Between Early and Late Responses in Patients With Ph+ CML in Chronic Phase: Post-Hoc Analyses of Molecular Monitoring of Imatinib Response in the RIGHT Study Read more about Feasibility of Peripheral Blood Sampling and Correlation Between Early and Late Responses in Patients With Ph+ CML in Chronic Phase: Post-Hoc Analyses of Molecular Monitoring of Imatinib Response in the RIGHT Study